Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies

Mark D Stewart; Valsamo Anagnostou

doi:10.1136/jitc-2022-006367

Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies

J Immunother Cancer. 2023 Jan;11(1):e006367. doi: 10.1136/jitc-2022-006367.

Authors

Mark D Stewart¹, Valsamo Anagnostou²

Affiliations

¹ Friends of Cancer Research, Washington, DC, USA.
² Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA vanagno1@jhmi.edu.

Abstract

Liquid biopsies are gaining momentum as minimally invasive means for cancer detection, characterization, monitoring, and interception. Composed of five expert-opinion review articles and five accompanying expert-physician viewpoints, this Journal for ImmunoTherapy of Cancer Special Review Series focuses on capturing and synthesizing the current state of science of liquid biopsies and their clinical relevance for cancer immunotherapy and beyond.

Keywords: Biomarkers, Tumor; Genetic Markers; Translational Medical Research.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Biology
Expert Testimony*
Humans
Immunotherapy
Liquid Biopsy
Neoplasms* / diagnosis
Neoplasms* / therapy